tradingkey.logo
tradingkey.logo
Search

Apogee Therapeutics Inc

APGE
Add to Watchlist
134.090USD
-0.210-0.16%
Close 07-31 16:00ETQuotes delayed by 15 min
10.11BMarket Cap
LossP/E TTM

APGE Financials

See Apogee Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Apogee Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-1.06/-1.10
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-4.22
-27.74%
Analyst Rating
HOLD
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
Financial Indicators
EPS
-11.87%-1.06
12.27%-1.03
-28.18%-1.11
-89.06%-1.13
-67.01%-0.95
-82.41%-1.17
-98.86%-0.86
-50.86%-0.60
-116.45%-0.57
---0.64
---0.43
---0.40
---0.26
----
----
Net Profit
-33.92%-74.11M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.10M
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
----
---4.30M
Operating profit
-31.18%-82.77M
-2.87%-78.06M
-21.46%-71.28M
-65.82%-73.17M
-65.25%-63.10M
-104.23%-75.88M
-141.46%-58.69M
-133.64%-44.12M
-201.64%-38.18M
---37.16M
---24.30M
---18.89M
-194.03%-12.66M
----
---4.30M
Net Profit
-33.92%-74.11M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.10M
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
----
---4.30M
Current assets
105.89%1.07B
39.95%741.36M
1.05%540.10M
-24.31%516.12M
-36.45%521.53M
32.96%529.71M
25.34%534.48M
421.82%681.85M
477.82%820.61M
--398.41M
--426.42M
--130.67M
--142.02M
----
----
Total current liabilities
-0.02%32.95M
-2.29%27.91M
4.40%34.05M
28.17%31.55M
52.94%32.96M
38.92%28.56M
89.84%32.61M
39.75%24.62M
92.52%21.55M
--20.56M
--17.18M
--17.61M
--11.19M
----
----
Total assets
81.14%1.29B
24.30%937.13M
-19.34%626.16M
-17.85%657.77M
-13.29%714.16M
87.83%753.95M
82.05%776.29M
512.75%800.66M
479.97%823.66M
--401.40M
--426.42M
--130.67M
--142.02M
----
----
Total liabilities
-7.20%37.86M
-10.51%33.25M
-4.93%39.82M
42.02%38.37M
83.94%40.80M
72.90%37.16M
143.82%41.88M
53.38%27.02M
98.15%22.18M
--21.49M
--17.18M
--17.61M
--11.19M
----
----
Total equity
86.50%1.26B
26.10%903.88M
-20.16%586.34M
-19.94%619.40M
-15.98%673.36M
88.67%716.79M
79.45%734.40M
584.32%773.64M
512.64%801.48M
--379.91M
--409.24M
--113.05M
--130.82M
----
----
Net operating income
-14.63%-55.57M
7.42%-62.69M
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.30M
-199.67%-31.64M
---29.75M
---19.88M
---14.57M
---10.56M
----
--0.00
Net investment
-372.29%-35.35M
-722.48%-288.63M
112.26%17.95M
152.54%78.13M
125.09%12.98M
216.82%46.37M
37.50%-146.38M
---148.71M
---51.74M
---39.69M
---234.22M
----
----
----
----
Net financing
66004.02%411.17M
745.32%374.95M
5053.52%19.74M
886.67%1.18M
-99.86%622.00K
20924.41%44.36M
-99.88%383.00K
91.15%-150.00K
--450.52M
---213.00K
--317.30M
---1.69M
-100.00%0.00
----
--5.00M

FAQs

What are the current assets of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its current assets were 741.36M, with a year-on-year change of 39.95.

What are the total assets of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its total assets of Apogee Therapeutics Inc were 937.13M, with a year-on-year change of 24.30.

What are the total liabilities of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its total liabilities of Apogee Therapeutics Inc were 33.25M, with a year-on-year change of -10.51.

What is the total equity of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its total equity of Apogee Therapeutics Inc was 903.88M, with a year-on-year change of 26.10.

What is the net operating income of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its net operating income of Apogee Therapeutics Inc was -285.60M, with a year-on-year change of -31.69.

What is the net investment of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its net investment of Apogee Therapeutics Inc was -179.57M, with a year-on-year change of 40.23.

What is the net financing of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its net financing of Apogee Therapeutics Inc was 396.49M, with a year-on-year change of -19.92.

What is the Earnings Per Share (EPS) of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.22, with a year-on-year change of -27.74.

What is the net income of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its net income was -255.84M, with a year-on-year change of -40.46.

What is the Return on Equity (ROE) of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -31.57, with a year-on-year change of 4.95.

What is the Return on Assets (ROA) of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -30.26, with a year-on-year change of 4.04.

What is the operating profit of Apogee Therapeutics Inc?

According to Apogee Therapeutics Inc's FY2025 earnings report, its operating profit was -285.60M, with a year-on-year change of -31.69.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.